Aerovate Therapeutics, Inc. (AVTE)

Last Year

03-May-23 -- 02-May-24

Time Period:

($21.53K) Net Amount

Buy:	0	--
Sell:	($21.53K)	$10.42 - $10.46

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

1

(3)

0

(2)

0

(1)

8

0

0

+1

0

+2

0

+3

Two Year Chart

03-May-22 -- 02-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
19-Apr-24 6:00 PM View:	17-Apr-24 Planned Option Sale ($153.33K)	Dake Benjamin T See Remarks		Aerovate Therapeutics, Inc. - AVTE	0% 1.29K	0	0	--	--	Show Txns Hide Txns

12-Apr-24 6:00 PM View:	10-Apr-24 Planned Option Sale ($201.39K)	Eldridge George A See Remarks		Aerovate Therapeutics, Inc. - AVTE	0% 1.96K	0	0	--	--	Show Txns Hide Txns

19-Apr-24 6:00 PM View:	17-Apr-24 Planned Option Sale ($89.52K)	Gillies Hunter Chief Medical Officer		Aerovate Therapeutics, Inc. - AVTE	0% 3.25K	0	0	--	--	Show Txns Hide Txns

18-Apr-24 6:00 PM View:	16-Apr-24 Planned Option Sale ($246.97K)	Noyes Timothy P Chief Executive Officer Director		Aerovate Therapeutics, Inc. - AVTE	0% --	0	($11.38K) (100%)	--	$10.42	Show Txns Hide Txns

11-Apr-24 6:00 PM View:	09-Apr-24 Private Sale ($334.48K)	Grayzel David S. Director		Aerovate Therapeutics, Inc. - AVTE	(1%) 1.81M to 1.8M	0	0	--	--	Show Txns Hide Txns

07-Feb-24 6:00 PM View:	05-Feb-24 Planned Option Sale ($80.25K)	Niven Ralph Chief Scientific Officer		Aerovate Therapeutics, Inc. - AVTE	0% 1.61K	0	0	--	--	Show Txns Hide Txns

03-Apr-24 6:00 PM View:	01-Apr-24 Planned Option Sale ($154.70K)	Verwijs Marinus CHIEF TECHNICAL OFFICER		Aerovate Therapeutics, Inc. - AVTE	(100%) 0.76K to 0	0	($10.15K) (128%)	--	$10.46	Show Txns Hide Txns